Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ProQR Therapeutics N.V. - Ordinary Shares
(NQ:
PRQR
)
1.670
+0.040 (+2.45%)
Delayed Quote
Updated: 4:00 PM EDT, Oct 5, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about ProQR Therapeutics N.V. - Ordinary Shares
< Previous
1
2
3
4
5
Next >
ProQR Reports First Human Validation of RNA Editing Platform in Liver Disease
↗
October 02, 2026
ProQR Therapeutics (NASDAQ:PRQR) said its first-in-human data for AX-0810 provided dose-dependent evidence that its RNA-editing approach can modulate NTCP, a liver transporter involved in bile acid...
Via
MarketBeat
ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor
September 23, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026
September 09, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR to Participate in Upcoming Investor Conferences in September 2026
September 02, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Second Quarter 2026 Operating and Financial Results
August 13, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Prices $50.0 Million Underwritten Registered Direct Offering and Concurrent Private Placement
June 25, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Positive Phase 1 Target Engagement Data for AX-0810, Establishing First Clinical Validation of the Axiomer RNA Editing Platform
June 25, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces First Quarter 2026 Operating and Financial Results
May 12, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Multiple Upcoming Scientific Conference Presentations Highlighting the Breadth of its Axiomer™ RNA Editing Platform
May 11, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Annual General Meeting of Shareholders to be Held June 2, 2026
May 04, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Nomination of Dr. Lykke Hinsch Gylvin to its Board of Directors
April 30, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
Wondering what's happening in today's pre-market session?
↗
March 30, 2026
Via
Chartmill
ProQR to Host Virtual Investor and Analyst Event Highlighting Pipeline on April 8, 2026
March 25, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Year End 2025 Operating and Financial Results
March 12, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Webcast of Presentation at the 2026 Citizens Life Sciences Conference
March 03, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Planned Changes to Board Composition
February 09, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Encouraging AX-0810 Phase 1 Safety and PK Data, Development Candidate Selections, and 2026 Outlook
January 08, 2026
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR to Participate in 8th Annual Evercore Healthcare Conference
December 01, 2025
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Third Quarter 2025 Operating and Financial Results
November 06, 2025
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Receives CTA Authorization for AX-0810 and Announces Virtual Investor and Analyst Event on November 3, 2025
October 20, 2025
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
Curious about the stocks that are showing activity after the closing bell on Thursday?
↗
October 16, 2025
The US market regular session of Thursday is over, let's have a look at the top gainers and losers in the after hours session today.
Via
Chartmill
ProQR to Participate in Upcoming Investor Conferences in October 2025
October 13, 2025
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
September 16, 2025
Via
Benzinga
ProQR Announces Second Quarter 2025 Operating and Financial Results
August 07, 2025
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Upcoming Presentation at RNA Editing Summit
July 28, 2025
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces CTA Submission for Phase 1 Study of AX-0810 Targeting NTCP
June 26, 2025
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Upcoming Scientific Presentations at ASGCT and TIDES Conferences
May 12, 2025
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces First Quarter 2025 Operating and Financial Results
May 08, 2025
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Webcast of Presentation at the 2025 Citizens Life Sciences Conference
May 02, 2025
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
ProQR Announces Annual General Meeting of Shareholders to be Held June 3, 2025
May 01, 2025
From
ProQR Therapeutics N.V.
Via
GlobeNewswire
< Previous
1
2
3
4
5
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
